The Influence of Prostaglandin E1 and Use of Inhibitor Percentage on the Correlation between the Multiplate and VerifyNow in Patients on Dual Antiplatelet Therapy

A.M. Hulshof, M. Vries, P. Verhezen, R. Wetzels, M. Haartmans, R. Olie, H. Ten Cate, Y. Henskens

Research output: Contribution to journalArticleAcademicpeer-review

4 Citations (Web of Science)
Original languageEnglish
Pages (from-to)463-468
Number of pages6
JournalPlatelets
Volume32
Issue number4
Early online date23 Apr 2020
DOIs
Publication statusPublished - 19 May 2021

Keywords

  • acute coronary syndrome
  • aggregation
  • aggregometry
  • citrate
  • clinical-outcomes
  • clopidogrel
  • different anticoagulants
  • function tests
  • inhibitor percentage
  • multiplate adp
  • multiplate adp-hs
  • platelet function tests
  • prostaglandin e1
  • treatment platelet reactivity
  • verifynow p2y12
  • whole-blood
  • FUNCTION TESTS
  • Multiplate ADP
  • AGGREGOMETRY
  • WHOLE-BLOOD
  • CLOPIDOGREL
  • prostaglandin E1
  • CITRATE
  • TREATMENT PLATELET REACTIVITY
  • CLINICAL-OUTCOMES
  • Inhibitor percentage
  • Multiplate ADP-HS
  • VerifyNow P2Y12
  • DIFFERENT ANTICOAGULANTS
  • ACUTE CORONARY SYNDROME
  • AGGREGATION

Cite this